- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00627237
Improving Executive Functioning After Traumatic Brain Injury (TBI): A Trial of the "Short Term Executive Plus" Program (STEP)
September 23, 2013 updated by: Icahn School of Medicine at Mount Sinai
Short-Term Executive Plus (STEP): A Randomized Controlled Trial of Short Term Intensive Cognitive Rehabilitation.
The purpose of this study is to determine the efficacy of an intensive short term cognitive rehabilitation program aimed towards improving executive functioning in individuals with traumatic brain injury (TBI).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Executive dysfunction following brain injury (BI) is commonly observed and has been well documented in the literature (Mateer, 1999; Prigatano, 1999; Levine et al., 2000; Shallice & Burgess, 1991; Cicerone & Giacino, 1992; Goldman-Rakic, 1993; Lezak, 1995, Riegal & Gauggel, 2002; McDonald, 2002; Stuss and Levine, 2003).
Level of functioning such as vocational success, community reintegration, and social autonomy are associated with executive functioning abilities following BI (Mazaux et al. 1997, Sohlberg, Mateer, & Stuss, 1993; (Stuss & Levine, 2002, McDonald, 2002).
Studies describing the rehabilitation of executive dysfunction have been limited to mostly single case or small group designs (Cicerone, et al., 2000).
However, there have been three small randomized clinical trials that have had promising results suggesting the need for more research in this area.
When considering all of the studies, it is evident that emphasis has been placed on three areas of intervention: attention remediation, emotional regulation and problem-solving.
Consequently, given the pervasive disability found in individuals with BI that is secondary to executive function disorders and the promising, but limited, success of problem-solving-based interventions for executive functions, a randomized controlled trial (RCT) of the efficacy of a short-term, intensive executive function training program (Short-Term Executive Plus) is proposed.
The Short-Term Executive Plus (STEP) program will combine treatments and treatment approaches that have proved to be effective in previous studies and will be compared to "wait-list" control group.
This design was chosen because no appropriate control intervention exists.
In other words there is no "standard" rehabilitation treatment available to these individuals that could serve as an appropriate "control" condition/treatment.
As discussed earlier, cognitive remediation is typically delivered in extended full-time day treatment programs or weekly/bi-weekly individual sessions.
Using more traditional extended treatments as a control condition would be inappropriate, as persons who can participate in extended, full-time are not the target of the proposed intervention.
It is hypothesized that the STEP program will result in significant improvements in executive functioning (and related areas of attention, memory, community participation, and life satisfaction).
Study Type
Interventional
Enrollment (Actual)
101
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10029-6574
- Icahn School of Medicine at Mount Sinaï
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be 18 years old or older;
- Having a TBI as a result of a blow to the head followed by a loss of consciousness or period of being dazed and confused or a period of post traumatic amnesia or clinical signs of altered neurological function; this information must be medically documented (e.g., emergency medical record, hospital record, neuroradiological report, or neurological exam or record of physician's visit within 24 hours of injury);
- Being at least three months post-injury;
- Being English-speaking (treatment sessions will be conducted in English);
- Reporting executive dysfunction (by self or family);
- Being willing and able to participate in and travel to the program daily for three months;
- Being oriented to time, place and person;
- Having a full-scale IQ of at least 75;
- Having a score on the Galveston Orientation and Amnesia Test of 75 or more;
- Having communication skills adequate to participate in groups;
- Having at least a sixth-grade reading level (for testing and use of written materials);
- Being willing to complete questionnaires and interviews about mood, thinking skills, participation and the like; AND
- Agreeing to participate, i.e., completion of informed consent and HIPAA documents.
Exclusion Criteria:
- Have diminished mental capacity and as a result, are unable to sign informed consent;
- Active substance abuse;
- Active psychosis;
- Active suicidality;
- Disruptive or violent behavior to self or others;
- Current cognitive rehabilitation (this will not include current psychotherapy);
- No impairment on the FRSBE or WCST; OR
- Showing evidence of or a diagnosis of dementia or mild cognitive impairment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Immediate start
Starts the 12 week intervention immediately after enrollment
|
Participation in an intensive cognitive rehabilitation program 3 days a week (3 hours a day) for 12 weeks.
Each day consists of a 50 minutes of problem solving group, 50 minutes of individualized attention training, and a 50 minute emotional regulation group session with 10 minutes breaks between each module.
|
|
Experimental: Waitlist group
Starts the 12 week intervention 12 weeks after initial enrollment
|
Participation in an intensive cognitive rehabilitation program 3 days a week (3 hours a day) for 12 weeks.
Each day consists of a 50 minutes of problem solving group, 50 minutes of individualized attention training, and a 50 minute emotional regulation group session with 10 minutes breaks between each module.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Executive functioning
Time Frame: At the beginning of the intervention
|
At the beginning of the intervention
|
|
Executive functioning
Time Frame: At 12 weeks
|
At 12 weeks
|
|
Executive functioning
Time Frame: At 24 weeks
|
At 24 weeks
|
|
Executive functioning
Time Frame: At 6 months
|
At 6 months
|
|
Executive functioning
Time Frame: At 1 year post-intervention.
|
At 1 year post-intervention.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Attention
Time Frame: At the beginning of the intervention
|
At the beginning of the intervention
|
|
Attention
Time Frame: At 12 weeks
|
At 12 weeks
|
|
Attention
Time Frame: At 24 weeks
|
At 24 weeks
|
|
Attention
Time Frame: At 6 months
|
At 6 months
|
|
Attention
Time Frame: At 1 year post-intervention
|
At 1 year post-intervention
|
|
Depression and anxiety
Time Frame: At the beginning of the intervention
|
At the beginning of the intervention
|
|
Depression and anxiety
Time Frame: At 12 weeks
|
At 12 weeks
|
|
Depression and anxiety
Time Frame: At 24 weeks
|
At 24 weeks
|
|
Depression and anxiety
Time Frame: At 6 months
|
At 6 months
|
|
Depression and anxiety
Time Frame: At 1 year post-intervention
|
At 1 year post-intervention
|
|
Memory and learning
Time Frame: At the beginning of the intervention
|
At the beginning of the intervention
|
|
Memory and learning
Time Frame: At 12 weeks
|
At 12 weeks
|
|
Memory and learning
Time Frame: At 24 weeks
|
At 24 weeks
|
|
Memory and learning
Time Frame: At 6 months
|
At 6 months
|
|
Memory and learning
Time Frame: At 1 year post-intervention
|
At 1 year post-intervention
|
|
Participation, life satisfaction, and self-efficacy
Time Frame: At the beginning of the intervention
|
At the beginning of the intervention
|
|
Participation, life satisfaction, and self-efficacy
Time Frame: At 12 weeks
|
At 12 weeks
|
|
Participation, life satisfaction, and self-efficacy
Time Frame: At 24 weeks
|
At 24 weeks
|
|
Participation, life satisfaction, and self-efficacy
Time Frame: At 6 months
|
At 6 months
|
|
Participation, life satisfaction, and self-efficacy
Time Frame: At 1 year post-intervention
|
At 1 year post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Wayne Gordon, Ph.D., Icahn School of Medicine at Mount Sinaï
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (Actual)
July 1, 2012
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
February 20, 2008
First Submitted That Met QC Criteria
February 28, 2008
First Posted (Estimate)
February 29, 2008
Study Record Updates
Last Update Posted (Estimate)
September 24, 2013
Last Update Submitted That Met QC Criteria
September 23, 2013
Last Verified
September 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GCO 06-0939
- CE001171
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Traumatic Brain Injury
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
Hospital Sirio-LibanesUniversity of Sao Paulo; Ministry of Health, Brazil; Hospital Sao Rafael; PROAD... and other collaboratorsRecruitingBrain Injury Traumatic Severe | Brain Injury Traumatic Moderate | Post Traumatic EpilepsyBrazil
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
Institut National de la Santé Et de la Recherche...Institut National de Recherche en Informatique et en AutomatiqueRecruitingTBI (Traumatic Brain Injury)France
-
Children's Hospital Medical Center, CincinnatiUniversity of CincinnatiCompletedBrain Injury Traumatic MildUnited States
-
University of Texas Southwestern Medical CenterAlbert Einstein College of Medicine; National Institute of Neurological Disorders... and other collaboratorsRecruitingTBI (Traumatic Brain Injury) | TBI | Traumatic Brain Injury With Loss of Consciousness | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateUnited States
-
University of Sao Paulo General HospitalUnknownTraumatic Brain Injury | Severe Brain Injury | Closed Traumatic Brain InjuryBrazil
-
BrainScope Company, Inc.Active, not recruitingTBI (Traumatic Brain Injury) | Concussion, Brain | MTBI - Mild Traumatic Brain Injury | Closed Head InjuryUnited States
-
Queen Mary University of LondonCompleted
-
Toronto Rehabilitation InstituteCentre for Aging and Brain Health Innovation; Ontario Neurotrauma FoundationRecruitingBrain Injuries, Traumatic | Brain Injury, Chronic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateCanada
Clinical Trials on Immediate Start
-
University of Alabama at BirminghamCompletedPediatric CancerUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedPulmonary Tuberculosis | Multidrug Resistant Tuberculosis | Extensively Drug Resistant TuberculosisKorea, Republic of
-
The First Affiliated Hospital of Dalian Medical...Fudan University; Beijing Friendship Hospital; Chinese PLA General Hospital; First... and other collaboratorsCompletedChronic Kidney DiseaseChina
-
M.D. Anderson Cancer CenterRecruitingDyspneaUnited States
-
University of ArizonaNational Cancer Institute (NCI); Michigan State UniversityCompleted
-
University of California, San FranciscoCompleted
-
Karolinska InstitutetCompletedOut-Of-Hospital Cardiac Arrest | Cardiac Arrest, SuddenSweden
-
Universitaire Ziekenhuizen KU LeuvenNot yet recruitingIBD | Ulcerative Colitis (UC) | Crohn's Diseases
-
University of MiamiCompletedMental Health Wellness 1United States